Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 


Link between hypertension and vitamin D deficiency

Study locks in link between hypertension and vitamin D deficiency

A new genetic study led by University of South Australia epidemiologist Professor Elina Hyppönen has confirmed a causal link between high blood pressure (hypertension) and deficiencies in vitamin D.

The findings just published in the Lancet Diabetes and Endocrinology journal, drew on a sample of more than 146,000 records to assess the association.

“We set up a Mendelian randomisation study using genetic data from the D-CarDia collaboration involving more than 140,000 individuals of European ancestry from across Europe and North America,” Prof Hyppönen says.

“We used two common genetic variants that affect circulating 25-hydroxyvitamin D concentrations, which are generally used to determine a person’s vitamin D status, to measure the causal effect between vitamin D status and blood pressure and hypertension risk.

“And what we found was that for each 10 per cent increase in 25-hydroxyvitamin D concentration there were drops in both diastolic and systolic blood pressure.

“Statistically the association translated to just over an eight percent decrease in the odds of developing hypertension.”

Prof Hyppönen says that while there have been some small scale studies and randomised trials, until now, a direct causal link between vitamin D and a lowering of blood pressure has not been shown.

“These findings may have important implications to individuals who are vitamin D deficient,” Prof Hyppönen believes. “The potential to prevent and reduce high blood pressure with vitamin D in place of more expensive medications is certainly something researchers can now usefully explore in greater depth.”

According to Prof Hyppönen while Mendelian randomisation helps to determine cause and effect by using genetic data and avoiding bias, there is always a possibility that the findings could occur by chance.

“What will be really important is an independent replication of this study,” Prof Hyppönen says.

“And to advance the work further, we need to do more research using randomised controlled studies to look at and confirm causality and importantly assess the clinical benefits of vitamin D supplements and dosage levels.”

This significant research into the relationship between vitamin D and hypertension was funded by the British Heart Foundation, UK Medical Research Council, and Academy of Finland.

Prof Hyppönen is a member of UniSA’s School of Population Health working at the South Australian Health and Medical Research Institute.

ends

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Inequality: Top 10% Of Housholds Have Half Of Total Net Worth

The average New Zealand household was worth $289,000 in the year to June 2015, Statistics New Zealand said today. However wealth was not evenly distributed, with the top 10 percent accounting for around half of total wealth. In contrast, the bottom 40 percent held 3 percent of total wealth. More>>

ALSO:

What Winter? Temperature Records Set For June 20-22

The days around the winter soltice produced a number of notably warm tempertaures. More>>

Conservation Deal: New Kākāpō Recovery Partnership Welcomed

Conservation Minister Maggie Barry says the new kakapo recovery partnership between DOC and Meridian Energy is great news for efforts to save one of New Zealand’s most beloved birds. More>>

ALSO:

Tech Sector Report: Joyce Warns Asian Tech Investors View NZ As Hobbits And Food

Speaking in Wellington at the launch of a report showcasing the value of the technology sector to the New Zealand economy, Joyce said more had to be done to tell the country's technology stories overseas. More>>

ALSO:

Mediaglommeration: APN Gets OIO Approval For Demerger Plan

APN News & Media has received Overseas Investment Office approval for its plan to split out its NZME unit ahead of a potential merger with rival Fairfax Media's New Zealand operations. More>>

New Paper: Ninety-Day Trial Period Has No Impact On Firms' Hiring

The introduction of a 90-day trial period has had no impact on hiring by New Zealand companies although they are now in widespread use, according to researchers at Motu Economic and Public Policy Research. More>>

ALSO:

Corrections: Serco Exits Equity Stake, Remains As Operator

Serco has sold its equity stake in the company that holds the contract to design, build and run Wiri Prison in South Auckland but continues as sub-contractor to operate the facility. More>>

GDP: NZ Economy Grows Faster-Than-Forecast 0.7%

New Zealand's economy grew at a faster pace than expected in the first quarter of 2016 as construction expanded at the quickest rate in two years. The kiwi dollar jumped after the data was released. More>>

ALSO:

Get More From Scoop

 
 
 
 
 
 
 
 
 
Sci-Tech
Search Scoop  
 
 
Powered by Vodafone
NZ independent news